Key result
Applying the V Brazilian Guidelines for dyslipidemia in pregnancy yielded an 83.8% prevalence compared to 19.6% using gestational age percentiles, with no superiority in predicting comorbidities.
Why the study?
Does the use of percentiles criteria compared to the V Brazilian Guidelines change the prevalence of dyslipidemia and its association with comorbidities in pregnant women?
Observational (n=433)
Does the use of percentiles criteria compared to the V Brazilian Guidelines change the prevalence of dyslipidemia and its association with comorbidities in pregnant women?
Absolute Event Rate: 83.8% vs 19.6%
The prevalence of dyslipidemia in pregnancy varies widely depending on the diagnostic criteria used, but neither criteria showed superiority in predicting maternal comorbidities.
Criteria from national guidelines inflate dyslipidemia prevalence in pregnancy without superior comorbidity prediction; leaves open optimal diagnostic thresholds for prospective validation.
Background: There is a physiologic elevation of total cholesterol (TC) and triglycerides (TG) during pregnancy. Some authors define dyslipidemia (DLP) in pregnant women when TC, LDL and TG concentrations are above the 95th percentile (p95%) and HDL concentration is below the 5th percentile (P5%) for gestational age (GA). Objective: To compare the prevalence of DLP in pregnant women using percentiles criteria with the V Brazilian Guidelines on Dyslipidemia and the association with maternal and fetal outcomes. Results: Pregnant women with high-risk conditions, aged 18-50 years, and at least one lipid profile during pregnancy was classified as the presence of DLP by two diagnostic criteria. Clinical and laboratorial data of mothers and newborns were evaluated. Conclusion: 433 pregnant women aged 32.9 ± 6.5 years were studied. Most (54.6%) had lipid profile collected during third trimester. The prevalence of any lipid abnormalities according to the criteria of the National Guidelines was 83.8%: TC ≥ 200 mg/dL was found in 49.9%; LDL ≥ 160 mg/dL, in 14.3%, HDL ≤ 50 mg/dL in 44.4% and TG ≥ 150 mg/dL in 65.3%. Any changes of lipid according to percentiles criteria was found in 19.6%: elevation above the P95% for TC was found in 0.7%; for LDL, 1.7%; for TG 6.4% and HDL lower than the P5% in 13%. The frequency of comorbidity: hypertension, diabetes, smoking, obesity and preeclampsia was similar among pregnant women when DLP was compared by both criteria. Conclusion: The prevalence of DLP during pregnancy varies significantly depending on the criteria used, however none demonstrated superiority in association with comorbidities.
No takes yet. Share an insight, caveat, or question.
Feitosa et al. (2017) conducted an observational in Dyslipidemia in pregnancy (n=433). V Brazilian Guidelines on Dyslipidemia criteria vs. Gestational age percentiles criteria was evaluated on Prevalence of any lipid abnormalities (dyslipidemia). Applying the V Brazilian Guidelines for dyslipidemia in pregnancy yielded an 83.8% prevalence compared to 19.6% using gestational age percentiles, with no superiority in predicting comorbidities.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: